LifeMD Inc (LFMD) is not a strong buy at this moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the technical indicators show some positive momentum, the lack of significant trading trends, weak financial performance, and absence of strong catalysts make it a hold rather than a buy.
The MACD histogram is positive at 0.0568 and expanding, indicating bullish momentum. RSI is neutral at 58.261, and moving averages are converging, suggesting no clear trend. The stock is trading near resistance levels (R1: 3.082), with support at 2.62. Overall, the technical indicators are moderately positive but not strong enough for a decisive buy signal.

The MACD is expanding positively, and the stock has a 50% chance of slight gains in the next week. Hedge funds and insiders are neutral, which avoids negative pressure.
No recent news or significant trading trends. Financial performance shows declining net income (-15.67% YoY) and EPS (-23.08% YoY). Gross margin has also dropped by 3.20% YoY. The stock has a higher probability of declining (-1.33%) over the next month. No recent congress trading data or influential figure activity.
In Q3 2025, revenue increased by 12.95% YoY to $60.17M, but net income dropped by 15.67% YoY to -$4.58M. EPS declined by 23.08% YoY to -0.1, and gross margin fell by 3.20% YoY to 87.69%. The financials indicate revenue growth but worsening profitability.
No data on analyst ratings or price target changes is available for LFMD at this time.